• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗心律失常药物的药代动力学临床应用。

Clinical application of pharmacokinetics for antiarrhythmic drugs.

作者信息

Harrison D C

出版信息

Arch Mal Coeur Vaiss. 1981 Dec;74 Spec No:65-72.

PMID:6803703
Abstract

Tables 3 and 4 summarize the important pharmacokinetic characteristics of commonly-used antiarrhythmic agents. Pharmacokinetic principles are just as important to the clinician as they are to pharmacologists. For the pharmacologist they define the time course of processes involved in the absorption, distribution, metabolism and elimination of drugs. For the clinician they provide basis for administering drugs to patients with disease processes which require a specific agent. Plasma concentration is generally related to efficacy and safety for many antiarrhythmic drugs and understanding the principles related to drug concentration in individual patients is necessary for rational use of many cardioactive agents. This paper provides an approach for the clinician to utilize the basic concepts of pharmacokinetics in practice.

摘要

表3和表4总结了常用抗心律失常药物的重要药代动力学特征。药代动力学原理对临床医生和药理学家同样重要。对药理学家而言,它们定义了药物吸收、分布、代谢和消除过程的时间进程。对临床医生而言,它们为给患有需要特定药物的疾病过程的患者用药提供了依据。对于许多抗心律失常药物,血浆浓度通常与疗效和安全性相关,了解个体患者药物浓度相关原理对于合理使用许多心血管活性药物是必要的。本文为临床医生在实践中运用药代动力学基本概念提供了一种方法。

相似文献

1
Clinical application of pharmacokinetics for antiarrhythmic drugs.抗心律失常药物的药代动力学临床应用。
Arch Mal Coeur Vaiss. 1981 Dec;74 Spec No:65-72.
2
New concepts for antiarrhythmic drugs in the 1980's.20世纪80年代抗心律失常药物的新概念。
Arch Mal Coeur Vaiss. 1981 Dec;74 Spec No:73-7.
3
Drug therapy of cardiac arrhythmias.心律失常的药物治疗
Cardiol Clin. 1983 May;1(2):305-22.
4
[Importance of pharmacokinetic studies in the clinical phase of experimentation with anti-arrhythmia agents].[药代动力学研究在抗心律失常药物临床试验阶段的重要性]
Arch Mal Coeur Vaiss. 1981 Dec;74 Spec No:57-64.
5
[Plasma levels of anti-arrhythmic drugs and clinical effectiveness in the treatment of ventricular arrhythmias].[抗心律失常药物的血浆水平及治疗室性心律失常的临床疗效]
G Ital Cardiol. 1986 Aug;16(8):648-59.
6
[Age-related characteristics of potassium glutamate pharmacokinetics].[谷氨酸钾药代动力学的年龄相关特征]
Farmakol Toksikol. 1984 Mar-Apr;47(2):58-61.
7
[Determination of plasma concentrations of anti-arrhythmia agents].
Arch Mal Coeur Vaiss. 1981 Dec;74 Spec No:47-55.
8
Cardiac arrhythmias: the role of pharmacologic intervention.心律失常:药物干预的作用
Cardiol Clin. 1989 May;7(2):299-318.
9
Clinical pharmacology of antiarrhythmic drugs: variability of metabolism and dose requirements.抗心律失常药物的临床药理学:代谢变异性与剂量需求
J Cardiovasc Pharmacol. 1991;17 Suppl 6:S74-6.
10
[Pharmacokinetics of the new Soviet anti-arrhythmia preparation etacizin].[苏联新型抗心律失常制剂乙胺碘呋酮的药代动力学]
Farmakol Toksikol. 1984 Mar-Apr;47(2):52-4.